West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Sales | 1,051,100 | 1,020,100 | 913,300 | 699,700 | 541,600 |
| Cost of Goods | 748,500 | 728,300 | 648,500 | 503,200 | 384,500 |
| Gross Profit | 302,600 | 291,800 | 264,800 | 196,500 | 157,100 |
| Operating Expenses | 179,000 | 197,200 | 164,300 | 123,300 | 108,200 |
| Operating Income | 124,100 | 94,900 | 101,000 | 73,400 | 49,400 |
| Interest Expense | 16,000 | 14,500 | 12,700 | 14,100 | 8,500 |
| Other Income | 2,200 | 8,500 | -1,900 | 4,500 | 4,900 |
| Pre-tax Income | 110,300 | 88,900 | 86,400 | 63,800 | 45,800 |
| Income Tax | 23,700 | 17,200 | 24,600 | 17,700 | 11,500 |
| Net Income Continuous | 86,600 | 71,700 | 61,500 | 46,000 | 34,300 |
| Net Income Discontinuous | N/A | -500 | 5,600 | 400 | -14,100 |
| Minority Interests | 600 | 500 | N/A | N/A | N/A |
| Net Income | $86,000 | $70,700 | $67,100 | $46,400 | $20,200 |
| EPS Basic Total Ops | 1.33 | 1.08 | 1.05 | 0.75 | 0.34 |
| EPS Basic Continuous Ops | 1.34 | 1.09 | 0.96 | 0.74 | 0.57 |
| EPS Basic Discontinuous Ops | N/A | -0.01 | 0.09 | 0.01 | -0.24 |
| EPS Diluted Total Ops | 1.25 | 1.03 | 1.00 | 0.71 | 0.33 |
| EPS Diluted Continuous Ops | 1.20 | 1.03 | 0.92 | 0.71 | 0.56 |
| EPS Diluted Discontinuous Ops | N/A | -0.01 | 0.09 | 0.01 | -0.23 |
| EBITDA(a) | $184,700 | $151,500 | $153,700 | $120,800 | $82,600 |